Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...

Germinal centers are high-speed evolution machines. Tiny clusters in the lymph nodes, germinal centers refine antibodies ...

Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...

Next, the researchers will work to design bispecific antibodies that would be effective against all coronaviruses, the virus ...

VUMC received up to $30M to develop AI for antibody therapy discovery, aiming to create an antibody-antigen atlas and ...

A Stanford-led team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its ...

Recent advances in the area are now also impacting more complex tasks, such as design and optimisation of antibodies. As a result, 2022 saw a breakthrough when the first ever computationally ...

This new platform integrates computational design and directed evolution to develop new antibodies, which are then screened for their ability to bind to target aggregates or inhibit the ...

This research marks an important milestone in AI-driven antibody discovery, demonstrating the successful design of antibodies against six distinct therapeutic targets, including a target without ...